Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Bulletin Du Cancer|December 24, 2009
[Lung cancer: an update in 2010]B Besse, S Vignot, J-C Soria
Bulletin Du Cancer|May 13, 2009
[Targeting of the AKT-mTOR pathway in head and neck and lung cancer]S Vignot, S Haberer, B Besse
Bulletin Du Cancer|April 10, 2009
[Prognostic and predictive factors in lung cancer]H Marijon, A Bouyon, S Vignot, et al.
Bulletin Du Cancer|January 23, 2010
[Molecular targeted therapies in small-cell lung cancer]A Levy, G G Malouf, B Besse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2021
Small cell lung cancer: a slightly less orphan disease after immunotherapyJ Remon, M Aldea, B Besse, et al.
The British Journal of Dermatology|May 27, 2009
Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitorsA Osio, C Mateus, J-C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2012
Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancerB Besse, L C Tsao, D T Chao, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Efficacy of phase 1 trials in malignant pleural mesothelioma: description of a series of patients at a single institutionJ Raphael, G Le Teuff, A Hollebecque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2009
The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinomaD Planchard, J Domont, E Taranchon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapyB Besse, C Massard, V Haddad, et al.
Pageof 26